Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

21-Nov-2008

  • Synta tests prostate-cancer therapy (Boston Business Journal)

    Synta Pharmaceuticals Corp. treated the first patient in the clinical trial of its proprietary prostate-cancer drug elesclomol.


  • Swan recalls prostate cancer battle (Herald Sun)

    TREASURER Wayne Swan has spoken of his own battle with prostate cancer while announcing $7.5 million for a research centre for the disease.


  • Genetic Risk Factors May Tailor Prostate Cancer Screening Approaches (Science Daily)

    Five genetic risk markers for prostate cancer may allow physicians to adapt screening approaches for men at high-risk, particularly African-American men, according to new research.


  • Back to Prostate News Archive